文献速递冠心病外科

糖尿病对冠状动脉旁路移植术后长期结局的影响

The effect of diabetes on long-term outcomes in patients following coronary artery bypass grafting.
PubMed 文献 · Eur J Cardiothorac Surg · 2025-01-01

糖尿病与短期死亡和再次血运重建无关,30天MACCE、心梗、卒中发生率更低,但长期MACCE、死亡、卒中和心梗风险更高,10年再次血运重建无差异。

要点

  • 糖尿病与CABG术后短期死亡和再次血运重建无关。
  • 糖尿病与30天MACCE、心梗和卒中发生率更低相关。
  • 糖尿病与长期MACCE、死亡、卒中和心梗风险更高相关,10年再次血运重建无差异。

核心结论

  • 糖尿病患者CABG术后长期结局更差,长期心梗发生率增加而血运重建未受影响,提示糖尿病对微血管病变的负面影响可能大于对移植血管的影响。

研究设计与样本

  • PRIORITY为观察性队列研究,合并2项前瞻性多中心孤立CABG研究,随访信息来自行政数据库并截尾于干预后10年,基线差异用逆概率治疗加权平衡。

主要发现

  • 糖尿病未影响短期死亡率(OR 0.90,95%CI 0.73-1.10)和再次血运重建(OR 0.79,95%CI 0.42-1.49)。
  • 糖尿病与30天MACCE(OR 0.67,95%CI 0.60-0.76)、急性心梗(OR 0.60,95%CI 0.51-0.70)和卒中(OR 0.47,95%CI 0.28-0.77)发生率更低相关。
  • 糖尿病患者长期MACCE风险更高(加权HR 1.31,95%CI 1.26-1.37)、死亡风险更高(HR 1.45,95%CI 1.37-1.53)、卒中风险更高(HR 1.38,95%CI 1.25-1.53)、心梗风险更高(HR 1.39,95%CI 1.26-1.53)。
  • 糖尿病与10年再次血运重建发生率增加无关(HR 1.04,95%CI 0.96-1.12)。

临床怎么用

  • 对CABG术后糖尿病患者应重视长期随访管理,重点关注死亡、卒中和心梗风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Diabetes mellitus is a risk factor for coronary artery disease, but its role following coronary artery bypass grafting (CABG) is still unclear and few data on long-term outcomes are available. This study aimed to evaluate the impact of diabetes on long-term outcomes after CABG. METHODS: The PRIORITY (PRedictIng long-term Outcomes afteR Isolated coronary arTery bypass surgerY) project is an observational cohort study merging 2 prospective multicentre studies on isolated CABG. Follow-up information was obtained through administrative databases and was truncated 10 years after the intervention. Baseline differences between patients with and without diabetes were balanced with inverse probability of treatment weighting. RESULTS: The cohort consisted of 10 989 patients with complete follow-up information who underwent isolated CABG (diabetes 32.3%). Diabetes did not affect short-term mortality [odds ratio (OR) 0.90, 95% confidence interval (CI) 0.73-1.10] and repeat revascularization (OR 0.79, 95% CI 0.42-1.49), while it is related to lower incidence of 30-day major adverse cardiac and cerebrovascular events (OR 0.67, 95% CI 0.60-0.76), acute myocardial infarction (OR 0.60, 95% CI 0.51-0.70) and stroke (OR 0.47, 95% CI 0.28-0.77). Diabetic patients had a higher long-term risk for major adverse cardiac and cerebrovascular event [weighted hazard ratio (HR) 1.31, 95% CI 1.26-1.37], mortality (HR 1.45, 95% CI 1.37-1.53), as well as stroke (HR 1.38, 95% CI 1.25-1.53) and myocardial infarction (HR 1.39, 95% CI 1.26-1. 53). Diabetes had not been associated with an increased incidence of repeated revascularization up to 10 years (HR 1.04, 95% CI 0.96-1.12). CONCLUSIONS: Diabetic patients had worse long-term outcomes. Diabetes may have a greater negative impact on micro-vasculopathy than grafts, as evidenced by the increased long-term incidence of myocardial infarction without affecting myocardial revascularization.

来源:Eur J Cardiothorac Surg,查看原文。版权归原作者所有。

引用

  1. Barili F, Vitale N, D'Errigo P, et al. The effect of diabetes on long-term outcomes in patients following coronary artery bypass grafting. Eur J Cardiothorac Surg. 2025. PMID: 39936583. doi:10.1093/ejcts/ezaf024

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。